• Nifty Pharma rose 1.71% to 28,912.95 at 09:29 IST.
  • 18 of 20 member stocks were higher.
  • Sai Life Sciences had the largest gain at +6.22%.
  • The Nifty 50 was −0.12%.

Figures as of: 09:29 IST, Monday 9 November 2026

The Nifty Pharma index rose 1.71% to 28,912.95 at 09:29 IST on Monday 9 November 2026. This move follows a previous close of 28,427.75 for the index. Among the 20 member stocks, 18 were higher and 2 were lower. Sai Life Sciences led the index with a gain of 6.22%.

Nifty Pharma today

Nifty Pharma todaySource: NSE index and equity prices, 09:29 IST
Level Change today
Nifty Pharma (09:29 IST) 28,912.95 +1.71% (+485.20 points)
Previous close 28,427.75 –
Opened at 28,431.80 +0.01%
Day’s range 28,351.60 – 28,917.25 high +1.72% on the previous close
Nifty 50 24,957.45 −0.12%
India VIX 18.02 −1.95%

How it compares with other sectors

Sector indices today, by changeSource: NSE index and equity prices, 09:29 IST
Sector index Change today
Nifty Pharma +1.71%
Nifty Healthcare Index +1.43%
Nifty PSU Bank +1.22%
Nifty Media +0.61%
Nifty Bank +0.40%
Nifty Financial Services +0.33%
Nifty Energy −0.08%
Nifty Oil & Gas −0.12%
Nifty Chemicals Index −0.12%
Nifty Auto −0.20%
Nifty PSE −0.21%
Nifty FMCG −0.35%
Nifty Infrastructure −0.35%
Nifty India Consumption −0.37%
Nifty CPSE −0.57%
Nifty Realty −0.58%
Nifty Metal −0.62%
Nifty IT −0.91%

Nifty Pharma stocks today

Nifty Pharma member stocks, by changeSource: NSE index and equity prices, 09:29 IST. Volume is for the session so far against a full day’s 20-session average.
Stock Price Change Volume vs average
Sai Life Sciences ₹1,852.50 +6.22% 0.64×
Gland Pharma ₹3,305.60 +5.52% 1.54×
Divi’s Laboratories ₹11,580.50 +4.36% 0.65×
Mankind Pharma ₹2,656.00 +2.83% 0.15×
Wockhardt ₹2,039.00 +1.63% 0.15×
Ipca Laboratories ₹1,969.00 +1.56% 0.11×
Biocon ₹372.95 +1.55% 0.08×
Alkem Laboratories ₹5,371.00 +1.26% 0.16×
Dr. Reddy’s Laboratories ₹1,385.20 +1.11% 0.06×
Laurus Labs ₹2,396.00 +1.10% 0.21×
Zydus Lifesciences ₹1,211.70 +1.02% 0.03×
Piramal Pharma ₹248.33 +0.87% 0.06×
Aurobindo Pharma ₹1,814.60 +0.59% 0.09×
Lupin ₹2,007.40 +0.52% 0.04×
Cipla ₹1,412.80 +0.50% 0.08×
Ajanta Pharma ₹3,347.60 +0.28% 0.04×
Sun Pharmaceutical Industries ₹1,920.20 +0.27% 0.08×
Glenmark Pharmaceuticals ₹2,600.00 +0.20% 0.23×
Abbott India ₹26,650.00 −0.13% 0.03×
Torrent Pharmaceuticals ₹4,766.40 −0.14% 0.05×

With 18 of 20 stocks higher, Nifty Pharma ranks number 1 among 18 sector indices by change. Sai Life Sciences gained 6.22% while Torrent Pharmaceuticals was at −0.14%. The Nifty 50 index was at −0.12% during the same period.

Where Nifty Pharma stands

Where Nifty Pharma stands against earlier closesSource: NSE index history
Reference point Level Nifty Pharma now against it
Previous close (2026-11-08) 28,427.75 +1.71%
Close five sessions earlier (2026-11-03) 27,218.50 +6.23%
Close about a month ago (2026-10-09) 25,962.05 +11.37%
52-week high close (2026-11-08) 28,427.75 +1.71%
52-week low close (2026-02-01) 21,535.30 +34.26%

The index level of 28,912.95 is 1.71% higher than the previous close of 28,427.75. It stands 6.23% above the 27,218.50 level recorded on 2026-11-03. Compared to the close of 25,962.05 on 2026-10-09, the index is 11.37% higher.

Nifty Pharma: FAQs

How much has the Nifty Pharma index risen today?

Nifty Pharma rose 1.71% to 28,912.95 at 09:29 IST on Monday 9 November 2026, against a previous close of 28,427.75.

Which Pharma stock is rising the most today?

Sai Life Sciences had the largest gain at +6.22%, trading at ₹1,852.50 at 09:29 IST on Monday 9 November 2026.

Are all Pharma stocks up today?

18 of 20 stocks in Nifty Pharma were higher at 09:29 IST on Monday 9 November 2026.

How does Nifty Pharma compare with the Nifty 50 today?

Nifty Pharma was +1.71% against −0.12% for the Nifty 50 at 09:29 IST on Monday 9 November 2026.

This article is for information only and is not investment advice. Prices are from the National Stock Exchange. Calculations are by ThePip. Prices and figures move through the session; the time above says when these were read. Investments in securities are subject to market risks.